A consensus opinion amongst stakeholders as to benefits of obstructive sleep apnoea treatment for cardiovascular health.
Shane A LandrySiobhan BanksPeter A CistulliGarun S HamiltonLaure HéraudKristina KairaitisSteven LubkeSutapa MukherjeeTeanau RoebuckJoesph SodaDarren UmbersShantha M W RajaratnamDarren MansfieldPublished in: Respirology (Carlton, Vic.) (2018)
The panel believed that findings from large-scale randomized trials indicate that treatment of moderate-severe OSA has not been established to improve cardiovascular event or morbidity/mortality rates. Strong evidence supports the ability of treatment to reduce blood pressure. Whilst many panel members believed that treatment improves left ventricular function, some were uncertain of the clinical significance of this secondary endpoint measure derived from lesser quality evidence.